| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |